Sunday, January 16, 2022

Biden gets COVID-19 booster shot

President Joe Biden receives his COVID-19 vaccine booster shot on camera at the White House on Monday, just days after the CDC advisory committee recommended a third dose for some groups.

The third dose of the Pfizer-BioEntech vaccine has been approved by the FDA and CDC for people over the age of 65, people over the age of 18 with underlying health conditions, and those who are at high risk of catching the virus because of their occupation. has been approved for. .

Before receiving the injection, Biden continued to lay the blame on those who haven’t yet received the pill, which he says now make up about 23 percent of the population.

“That specific minority is doing a great deal of harm to the rest of the country among us,” he said. “This is an epidemic of the uneducated.”

The booster shot is to be taken 6 months after the two-shot primary series. Pharmacies are instructed to administer booster shots based on self-verification of people who say they are eligible to receive one.

“For example, there would be a temptation for people who have recently been vaccinated to not wait for a six-month period,” said infectious disease specialist Dr. Anthony Fauci. “There’s an immunological reason why waiting is important, because you know that if you let the immune response mature over a period of a few months, you get more blasts from the shot than, as it were, to increase your antibodies. In. “

The plan for booster shots was announced in August by eight top government doctors, with clear evidence that COVID-19 vaccine effectiveness diminishes over time. The Biden administration then planned to start giving Americans booster shots, with the goal starting on September 20.

On September 17, the FDA advisory committee voted 16-3 against providing boosters for most people, but recommended it for people over the age of 65 and those at high risk. The CDC committee made a similar recommendation last week.

There were some flaws in the approval process. Two of the FDA’s top vaccine officials, Dr. Marion Gruber, director of the FDA’s Office of Vaccine Research and Review, and her deputy, Dr. Philip Krauss, announced their plans to leave the agency late last month in October and November.

The two co-authored a paper released in the scientific journal The Lancet that said booster shots may only be appropriate for certain at-risk populations.

The article reads, “While the benefits of primary COVID-19 vaccination clearly outweigh the risks, there may be risks if boosters are widely introduced too soon, or too frequently, especially for those vaccines.” With immune-mediated side effects that can occur … if unnecessary boosting causes significant adverse reactions, there may be implications for vaccine acceptance that extend beyond COVID-19 vaccines. Thus, only widely promoted When there is clear evidence that it is justified.

Earlier this month, Biden issued an executive order calling for a new OSHA rule requiring all federal employees to receive the vaccine and fine businesses with more than 100 employees as long as they have to vaccinate their employees. No need to apply or receive weekly COVID-19 tests.

Biden is due to travel to Chicago on Wednesday to promote the plan and ask more businesses to implement vaccine mandates.


Nick Ciolino covers the White House.


This News Originally From – The Epoch Times

Nation World News Desk
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news
- Advertisement -